Clene agreed to sell 1,219,513 shares at $3.28 each to raise about $4.0M, including sales to directors and officers. The proceeds fund regulatory filings and manufacturing, but the below-market sale increases dilution, leaving the story balanced.
The raise brings roughly $4.0M that the company will use to advance CNM-Au8 filings and manufacturing. Selling shares at $3.28 increases share count and was done to insiders, so the benefits and dilution largely cancel each other.
Follow Clene Inc. (CLNN) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for CLNN